The ROE as of December 2024 (TTM) for DURECT Corporation (DRRX) is -232.73%

According to DURECT Corporation’s latest financial reports and current stock price. The company's current ROE is -232.73%. This represents a change of 76.52% compared to the average of -131.85% of the last 4 quarters.

DURECT Corporation (DRRX) Historical ROE (quarterly & annually)

How has DRRX ROE performed in the past?

The mean historical ROE of DURECT Corporation over the last ten years is -133.06%. The current -232.73% ROE has changed 74.90% with respect to the historical average. Over the past ten years (40 quarters), DRRX's ROE was at its highest in in the June 2017 quarter at 540.10%. The ROE was at its lowest in in the September 2024 quarter at -352.10%.

DURECT Corporation (DRRX) ROE by Quarter and Year

Discovering the peaks and valleys of DURECT Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DURECT Corporation (DRRX) Average ROE

How has DRRX ROE performed in the past?

The current ROE of DURECT Corporation (DRRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DURECT Corporation (DRRX) ROE vs. Peers

How is DRRX’s ROE compared to its peers?

DURECT Corporation’s ROE is greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), greater than Mallinckrodt plc (-74.45%), greater than Organogenesis Holdings Inc. (-2.69%), greater than Lucy Scientific Discovery Inc. (-296.96%), greater than Alimera Sciences, Inc. (-33.70%), greater than Alpha Teknova, Inc. (-37.32%), less than Agile Therapeutics, Inc. (104.04%), greater than Sonoma Pharmaceuticals, Inc. (-63.67%), less than Eagle Pharmaceuticals, Inc. (17.39%), less than Lifecore Biomedical, Inc. (17.23%), greater than RedHill Biopharma Ltd. (-103.24%), less than Taro Pharmaceutical Industries Ltd. (3.05%), less than Collegium Pharmaceutical, Inc. (40.81%), less than Neurocrine Biosciences, Inc. (15.68%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), greater than Ironwood Pharmaceuticals, Inc. (-7.63%), less than Alkermes plc (26.49%), greater than Avadel Pharmaceuticals plc (-93.32%), less than Aquestive Therapeutics, Inc. (62.93%), greater than Evoke Pharma, Inc. (-308.51%), less than Adamis Pharmaceuticals Corporation (0.33%), less than Guardion Health Sciences, Inc. (77.24%), greater than AcelRx Pharmaceuticals, Inc. (-118.55%),

Build a custom stock screener for DURECT Corporation (DRRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DURECT Corporation (DRRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.